Lawlor Sally Bridget
SEC insider (Form 3/4/5 filer). CIK 0002084407. Chief Financial Officer at Quoin Pharmaceuticals, Ltd. (QNRX). 3 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in ASHBURN, VA.
Companies Lawlor Sally Bridget has filed insider reports for
- Quoin Pharmaceuticals, Ltd. (QNRX): Officer, Chief Financial Officer
Lawlor Sally Bridget
CIK: 0002084407
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
QNRX
Quoin Pharmaceuticals, Ltd.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Aug 31, 2026QNRX
Quoin Pharmaceuticals, Ltd.
PurchaseDirect10.2K shares at avg. $4.88$50K - Feb 4, 2026QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
85.3K shares- - Dec 1, 2025QNRX
Quoin Pharmaceuticals, Ltd.
AwardDirectShare Option (Right to Buy)
10.3K shares-
1-3 of 3 transactions